Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.

Autor: Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wasylishen AR; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., Pieterman CRC; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht 3508 GA, the Netherlands., Irajizad E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Vykoukal J; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wu R; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dennison JB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhao H; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, VA 23284, USA., Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Halperin DM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Agarwal SK; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Blau JE; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Jha S; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Rivero JD; Developmental Therapeutics Branch, The National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Nilubol N; Surgical Oncology Program, The National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Walter MF; Core for Clinical Laboratory Services, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Welch JM; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Weinstein LS; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Vriens MR; Department of Surgical Oncology and Endocrine Surgery, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands.; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands., van Leeuwaarde RS; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., van Treijen MJC; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., Valk GD; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA., Perrier ND; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Katayama H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Nov 17; Vol. 108 (12), pp. 3260-3271.

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice.

Autor: van Beek DJ; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Pieterman CRC; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Wessels FJ; Department of Radiology, University Medical Center Utrecht, Utrecht, Netherlands., van de Ven AC; Department of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands., de Herder WW; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands., Dekkers OM; Departments of Endocrinology and Metabolism and Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands., Zandee WT; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Drent ML; Department of Internal Medicine, Section of Endocrinology, Amsterdam University Medical Center (UMC) Location Vrije Universiteit (VU) University Medical Center, Amsterdam, Netherlands., Bisschop PH; Department of Endocrinology and Metabolism, Amsterdam University Medical Center (UMC) Location Academic Medical Center, Amsterdam, Netherlands., Havekes B; Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Center, Maastricht, Netherlands., Borel Rinkes IHM; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Vriens MR; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Oct 07; Vol. 13, pp. 926491. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).

Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.

Autor: Landry JP; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX., Clemente-Gutierrez U; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX., Pieterman CRC; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX., Chiang YJ; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX., Waguespack SG; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX., Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX., Habra MA; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX., Halperin DM; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Fisher SB; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX., Graham PH; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX., Perrier ND; Department of Surgical Oncology, Section of Surgical Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: nperrier@mdanderson.org.

Publikováno v: Surgery [Surgery] 2022 Aug; Vol. 172 (2), pp. 559-566. Date of Electronic Publication: 2022 Apr 16.

Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.

Autor: Klein Haneveld MJ; Department of Endocrine Oncology, University Medical Centre Utrecht, 3584 CX, Utrecht, the Netherlands., van Treijen MJC; Department of Endocrine Oncology, University Medical Centre Utrecht, 3584 CX, Utrecht, the Netherlands., Pieterman CRC; Department of Endocrine Oncology, University Medical Centre Utrecht, 3584 CX, Utrecht, the Netherlands.; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Dekkers OM; Departments of Endocrinology and Metabolism and Clinical Epidemiology, Leiden University Medical Centre, 2333 ZA, Leiden, the Netherlands., van de Ven A; Department of Endocrinology, Radboud University Medical Center, 6525 GA, Nijmegen, the Netherlands., de Herder WW; Department of Internal Medicine, Erasmus Medical Center, 3015 GD, Rotterdam, the Netherlands., Zandee WT; Department of Endocrinology, University of Groningen, University Medical Centre Groningen, 9713 GZ, Groningen, the Netherlands., Drent ML; Department of Internal Medicine, Section of Endocrinology, Amsterdam UMC, location VU University Medical Centre, 1081 HV, Amsterdam, the Netherlands., Bisschop PH; Department of Endocrinology and Metabolism, Amsterdam UMC, location Academic Medical Centre, 1105 AZ, Amsterdam, the Netherlands., Havekes B; Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Centre, 6229 HX, Maastricht, the Netherlands., Vriens MR; Department of Endocrine Surgery, University Medical Centre Utrecht, 3584 CX, Utrecht, the Netherlands., Verrijn Stuart AA; Department of Paediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, 3584 EA, Utrecht, the Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Centre Utrecht, 3584 CX, Utrecht, the Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Centre Utrecht, 3584 CX, Utrecht, the Netherlands.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Nov 19; Vol. 106 (12), pp. 3515-3525.

It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 1.

Autor: Shirali AS; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pieterman CRC; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lewis MA; Department of Medicine, Intermountain Healthcare, Murray, Utah., Hyde SM; Department of Obstetrics and Gynecology-Cancer Genetics, Northwestern Memorial Hospital, Chicago, Illinois., Makawita S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thosani N; Division of Gastroenterology, Hepatology, and Nutrition, McGovern Medical School, UTHealth, Houston, Texas., Ikoma N; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Waguespack SG; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas., Perrier ND; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: CA: a cancer journal for clinicians [CA Cancer J Clin] 2021 Sep; Vol. 71 (5), pp. 369-380. Date of Electronic Publication: 2021 Jun 01.